Literature DB >> 10406274

Mesalamine-induced granulomatous hepatitis.

M Braun1, G M Fraser, M Kunin, F Salamon, R Tur-Kaspa.   

Abstract

A 42-yr-old man with ulcerative colitis was admitted for investigation of prolonged fever associated with cholestatic liver tests. Endoscopic retrograde cholangiopancreatography demonstrated a normal biliary tree, and liver biopsy showed granulomata. A clinical diagnosis of drug-induced granulomatous hepatitis was established as the symptoms disappeared after cessation of mesalamine therapy and recurred on rechallenge. Although the differential diagnosis of fever and hepatitis in patients with inflammatory bowel disease is wide, in this case mesalamine is the most likely cause.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10406274     DOI： 10.1111/j.1572-0241.1999.01245.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


  9 in total

1.  Current medical therapy of inflammatory bowel disease.

Authors:  Kiron M Das; Sherif A Farag
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 2.  Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

Authors:  María Rojas-Feria; Manuel Castro; Emilio Suárez; Javier Ampuero; Manuel Romero-Gómez
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

3.  An unusual cause of febrile hepatitis.

Authors:  Teresa Stelzer; Sibylle Kohler; Ewerton Marques Maggio; Ludwig Theodor Heuss
Journal:  BMJ Case Rep       Date:  2015-06-25

4.  Intrahepatic cholestasis in Bruton's agammaglobulinemia receiving mesalamine for co-morbid Crohn's disease.

Authors:  Giovanni Clemente Actis; Rinaldo Pellicano; Floriano Rosina
Journal:  J Pharmacol Pharmacother       Date:  2014-04

Review 5.  Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.

Authors:  Fotios S Fousekis; Vasileios I Theopistos; Konstantinos H Katsanos; Epameinondas V Tsianos; Dimitrios K Christodoulou
Journal:  Gastroenterology Res       Date:  2018-04-07

Review 6.  Hepatobiliary manifestations of inflammatory bowel disease in children.

Authors:  Magdalena Kucharska; Urszula Daniluk; Kamila Agnieszka Kwiatek-Średzińska; Natalia Wasilewska; Aleksandra Filimoniuk; Piotr Jakimiec; Katarzyna Zdanowicz; Dariusz Marek Lebensztejn
Journal:  Clin Exp Hepatol       Date:  2019-09-05

Review 7.  Hepatobiliary manifestations in inflammatory bowel disease: A practical approach.

Authors:  Paulina Núñez F; Fabiola Castro; Gabriel Mezzano; Rodrigo Quera; Diego Diaz; Lorena Castro
Journal:  World J Hepatol       Date:  2022-02-27

Review 8.  Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations.

Authors:  Cristina Bezzio; Cristina Della Corte; Marta Vernero; Imma Di Luna; Gianpiero Manes; Simone Saibeni
Journal:  Therap Adv Gastroenterol       Date:  2022-07-28       Impact factor: 4.802

Review 9.  Liver manifestations and complications in inflammatory bowel disease: A review.

Authors:  Rui Gaspar; Catarina Castelo Branco; Guilherme Macedo
Journal:  World J Hepatol       Date:  2021-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.